Issues surrounding biospecimen collection and use in clinical trials
Related Experiment Video
Updated: Jun 7, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Allison R Baer1, Mary Lou Smith, Deborah Collyar
1American Society of Clinical Oncology, Alexandria, VA; Research Advocacy Network, Plano, TX; Patient Advocates in Research, Danville, CA; and Duke University Medical Center, Chapel Hill, NC.
Abstract:
As the need for patient participation in biospecimen and correlative research increases, challenging ethical and potentially legal questions are emerging.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Ethical Issues
Ethical Concerns in Healthcare:
Clinical Trials: Overview
Ethics in Research

